Skip to content

Total debt at other companies

Bausch Health Companies logo
Bausch Health CompaniesBHC
$20.76B-3.5%
Cumberland Pharmaceuticals logo
Cumberland PharmaceuticalsCPIX
$4.83M-7.1%
PTH
Pelthos Therapeutics Inc.PTHS
$29.65M
Arcutis Biotherapeutics, Inc. logo
Arcutis Biotherapeutics, Inc.ARQT
$114.67M+3.5%
HRO
HarrowHROW
$308.58M-32.9%
Catalyst Pharmaceutical logo
Catalyst PharmaceuticalCPRX
$2.68M-13.3%

Other financials

Income statement

See full
Revenue$16.0M+21.5%
Gross profit$9.7M+16.7%
Operating income-$1.5M+55.1%
Net income-$2.2M+45.2%
EPS (diluted)-$0.08+55.6%

Balance sheet

See full
Cash & equivalents$27.2M+29.2%
Total equity$30.8M+43.1%
Total assets$91.5M+7.7%

Cash flow

See full
Operating cash flow$2.9M+203%
CapEx$3.8M
Free cash flow-$6.0M

Valuation

See full
Market cap$194.94M+20.9%
Enterprise value$193.19M+16.2%
P/S+0.2×

Profitability

See full
Gross margin65.4%-1.0pp
Operating margin-9.8%
Net margin-14.8%
FCF margin-43%

Returns & leverage

See full
Return on equity-36.6%
Debt / equity0.8×-0.3×
Current ratio1.7×+0.4×

Where this comes from

Calculated from Journey Medical Corporation’s reported figures.

The official record: Journey Medical Corporation’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Journey Medical Corporation's total debt.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Journey Medical Corporation's total debt?
Journey Medical Corporation (DERM) reported total debt of $25.47M in Q1 2026.
How has Journey Medical Corporation's total debt changed year-over-year?
Journey Medical Corporation's total debt increased by 1.2% year-over-year, from $25.17M to $25.47M.
What is the long-term trend for Journey Medical Corporation's total debt?
Over 5 years (2020 to 2025), Journey Medical Corporation's total debt has grown at a 168.5% compound annual growth rate (CAGR), from $182K to $25.4M.
What does total debt mean?
Total debt represents the aggregate sum of all interest-bearing financial obligations, including short-term borrowings, the current portion of long-term debt, and long-term debt instruments. It also encompasses capitalized lease liabilities and other debt-like financing arrangements that require fixed repayment schedules. This metric serves as a comprehensive indicator of a company's total financial leverage and its reliance on external capital providers.